Health Condition 1: N979- Female infertility, unspecified
Conditions
Interventions
Intervention1: Thymosin alpha one: Study participant has been administered a thymosin alpha-1 injection until Embryo transfer, dose determined by randomization
Control Intervention1: Not applicable: N
Sponsors
Aruna R
Eligibility
Inclusion criteria
Inclusion criteria: Failure of clinical pregnancy after 4 good quality embryo transfers, with at least three fresh or frozen IVF cycles, and in women under the age of 40 Two or more consecutive failed clinical pregnancies documented by ultrasound or histopathology Female participants who are willing to provide a voluntary written informed consent.
Exclusion criteria
Exclusion criteria: Female participants who have participated in another trial with an investigational drug within 1 month prior to this trial. Female participants who, in the judgment of the investigator, will be unlikely to comply with the requirements of this protocol. Female participants with a history of any clinically significant illness, in the opinion of the investigator, that may jeopardize the study results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implantation rateTimepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy rateTimepoint: 12 weeks of pregnancy | — |
Countries
India
Contacts
Public ContactDr Aruna R
A4 Hospital and Fertility centre Pvt Ltd
Outcome results
None listed